Authors: Joelle B. Karlik, MD; Geraldine C. Diaz, DO ASA Monitor June 2024, Vol. 88, Since the initial reports of successful renal transplantation in children, pediatric kidney transplantation has expanded to become the most common pediatric transplant in the United States (Am J Surg 1983;145:243-7; J Pediatr 1982;100:675-80; asamonitor.pub/3TSvo4u). Following the COVID-19 pandemic, pediatric kidney transplant activity has normalized, with annual […]
Read MoreAuthor: Robin Hocevar ASA Monitor June 2024, Vol. 88, Early in his career as an anesthesiologist, David Broussard, MD, was puzzled by the varied reactions of patients following complications while under anesthesia. On the one hand, he observed certain patients becoming very angry after experiencing only minor complications, while others appeared surprisingly forgiving following major medical […]
Read MoreAuthor: Amanda Burden, MD, FASA, FSSH ASA Monitor June 2024, Vol. 88, 9–10. Case presentation A 60-70-year-old ASA Physical Status 4 woman with a BMI of 36.9 and past medical history significant for coronary artery disease (CAD), status post-myocardial infarction (MI) and coronary artery bypass graft (CABG), congestive heart failure (CHF), asthma, chronic obstructive pulmonary […]
Read MoreAuthor: Muhammad A. Farooq Anwar, MD, MBA et al ASA Monitor June 2024, Vol. 88, 1–6. The IOM report “Relieving Pain in America” indicates that racial and socioeconomic disparities in pain treatment are common. There is a paucity of data regarding disparities in innovative pain procedures. Two existing studies discuss profound racial differences in patients receiving […]
Read MoreNovel gene therapy reduces risk of motor impairment in MLD The FDA has approved Lenmeldy (atidarsagene autotemcel) as the first gene therapy for children with presymptomatic late infantile, pre-symptomatic early juvenile, or early symptomatic early juvenile metachromatic leukodystrophy (MLD). MLD is a rare genetic disease affecting the brain and nervous system due to a deficiency […]
Read More